1 Min Read
Sept 13 (Reuters) - Sanofi Sa :
* Sanofi says Toujeo demonstrated a consistently lower rate of hypoglycemia compared to Lantus at all levels of HbA1c control Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.